Pro Share Advisors LLC Syros Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.69 - $1.21 $11,871 - $20,818	-17,205 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.02 - $3.8 $4,179 - $15,572	-4,098 Reduced 19.24%	17,205 $21,000
Q4 2021 Feb 08, 2022	BUY	$3.26 - $4.66 $2,268 - $3,243	696 Added 3.38%	21,303 $69,000
Q3 2021 Nov 12, 2021	SELL	$4.08 - $5.66 $22,207 - $30,807	-5,443 Reduced 20.89%	20,607 $92,000
Q2 2021 Aug 13, 2021	BUY	$5.01 - $7.48 $24,704 - $36,883	4,931 Added 23.35%	26,050 $142,000
Q1 2021 May 14, 2021	BUY	$7.19 - $14.95 $34,893 - $72,552	4,853 Added 29.84%	21,119 $158,000
Q4 2020 Feb 09, 2021	BUY	$6.66 - $14.66 $25,327 - $55,751	3,803 Added 30.51%	16,266 $176,000
Q3 2020 Nov 13, 2020	SELL	$8.69 - $14.47 $4,188 - $6,974	-482 Reduced 3.72%	12,463 $110,000
Q2 2020 Aug 03, 2020	BUY	$5.21 - $11.03 $67,443 - $142,783	12,945 New	12,945 $138,000
Q1 2020 May 15, 2020	SELL	$4.46 - $9.2 $61,882 - $127,649	-13,875 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$4.52 - $10.1 $7,051 - $15,756	-1,560 Reduced 10.11%	13,875 $96,000
Q3 2019 Nov 12, 2019	BUY	$7.14 - $11.65 $2,691 - $4,392	377 Added 2.5%	15,435 $160,000
Q2 2019 Aug 13, 2019	BUY	$5.5 - $9.75 $4,812 - $8,531	875 Added 6.17%	15,058 $139,000
Q1 2019 May 15, 2019	BUY	$5.51 - $9.59 $606 - $1,054	110 Added 0.78%	14,183 $130,000
Q4 2018 Feb 14, 2019	BUY	$5.55 - $11.34 $78,105 - $159,587	14,073 New	14,073 $78,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.